Regulatory Affairs
Regulatory Affairs
Solstice Medicine Company is committed to comply with all Federal and Local statutes and regulations. This commitment is further demonstrated by being transparent with our most highly valued business partners and ultimately to the consumers and users of these quality products.
Supplier qualification is an important part of any healthy business relationship. Therefore, our Quality Unit has compiled the following information to expedite your firm's supplier vetting policies and provide additional information regarding our business practices.
AZBOP Online Applications
Pursuant to A.R.S. 32-3214(C), a person may obtain additional public records related to any licensee or certificate holder, including dismissed complaints and nondisciplinary actions and orders, by contacting the Board directly https://azbop.igovsolution.net/online/Lookups/AZBusiness_Lookup.aspx
Our account number is 11711119692.
Click here to download the offical document.
Our number is W2-0004979.
A person may obtain additional public records related to any licensee or certificate holder, including dismissed complaints and nondisciplinary actions and orders, by contacting the Board directly at https://orbop.mylicense.com/Verification/Search.aspx?facility=Y
Solstice Medicine Company distributes products that require warning statements to California residents. These products may contain detectable amounts of naturally occurring toxins such as arsenic, cadmium, lead, and mercury. These elements are not added by man, or due to human activities. You can obtain more Proposition 65 information at www.P65warnings.ca.gov. To remain in compliance with Proposition 65 requirements Solstice routinely tests for the presents of listed chemicals and will label finished goods accordingly lot-by-lot.
For those valued wholesale partners to whom we ship product to a California address, Solstice Medicine Company acknowledges your distribution business model is not limited to the State of California. The products purchased from Solstice Medicine Company may be further be sold and distributed to customers outside the State of California. Solstice Medicine Company is willing to provide your firm with unlabeled product under the following conditions listed below.
It is your firm’s responsibility to ensure applicable products have prominent and conspicuous warning at the point of sale in California. Furthermore, you must appropriately notify those customers the product may expose a person to certain chemicals listed by the State of California which are known to cause cancer, birth defects, or other reproductive harm.
Solstice Medicine Company herby notifies your firm that products require a clear and reasonable warning to California based customers before knowingly and intentionally exposing them to listed chemical(s) as per California Health and Safety Code Section 25249.5 ET SEQ (hereinafter listed as P65). For more information go to: https://oehha.ca.gov/proposition-65
Solstice Medicine Company will ship product without a warning statement because your firm is requesting Solstice provide products without any on-product P65 warnings. Solstice is willing to comply with your request under the following conditions.
- Your firm sign this acknowledgment letter, commit to take all responsibility warning the California customers/consumers in full compliance with the regulations, and return the signed responsibility and indemnity letter to us.
- Your firm apply appropriate P65 warning stickers when sales are to California residents and be willing to send working examples upon our request.
Proposition 65 requires either of the following warning statement formats.
Short Format Warning
Full Format Warning
As a potential California distributor you agree to indemnify and hold harmless Solstice Medicine Company for any loss, damage, claim, injury, or expense, including attorneys’ fees, asserted against any of them, by reason of any injury, demand, claim or suit arising out of negligence its/her/his employees and/or agents, in connection with distributing of unlabeled products in the State of California.
We are available to answer questions you may have.
Los Angeles Department of Building and Safety Compliance Notice
LADBS EBEWE Compliance Notice
The building listed below has complied with the City of Los Angeles Existing Buildings Energy & Water Efficiency (EBEWE) Program (Ordinance No. 184674 as amended by Ordinance No. 195198) for the annual benchmarking report for calendar year 2021. Please keep the following information for your records.
Building Address :
215 W Ann St
Building ID No. :
491751846745
Calendar Year Reported :
2021
Compliance Date :
5/29/2022
Existing Buildings Energy and Water Efficiency Program (EBEWE)
Los Angeles Department of Building and Safety
City of Los Angeles